In agreement with the observed myeloid cells scores, we observed that the levels of CEBPB (CCAAT/enhancer-binding protein beta), VEGF (Vascular endothelial growth factor), TGFB1 (Transforming growth factor beta 1) and NOD2 (Nucleotide-binding oligomerization domain-containing protein 2) were significantly higher in tumors from AAs (as compared to their non-tumor counterpart). The gene discussed is CEBPB; the disease is neoplasm.